Tejas Mehta to Early Detection of Cancer
This is a "connection" page, showing publications Tejas Mehta has written about Early Detection of Cancer.
Connection Strength
1.165
-
Fazeli S, Narayan AK, Mango VL, Wahab R, Mehta TS, Ojeda-Fournier H. Access to Breast Cancer Screening: Disparities and Determinants-AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2025 Aug; 225(2):e2432151.
Score: 0.178
-
Niell BL, Jochelson MS, Amir T, Brown A, Adamson M, Baron P, Bennett DL, Chetlen A, Dayaratna S, Freer PE, Ivansco LK, Klein KA, Malak SF, Mehta TS, Moy L, Neal CH, Newell MS, Richman IB, Schonberg M, Small W, Ulaner GA, Slanetz PJ. ACR Appropriateness Criteria? Female Breast Cancer Screening: 2023 Update. J Am Coll Radiol. 2024 Jun; 21(6S):S126-S143.
Score: 0.172
-
Jackson T, Wahab RA, Bankston K, Mehta TS. Raising Cultural Awareness and Addressing Barriers to Breast Imaging Care for Black Women. J Breast Imaging. 2024 Jan 19; 6(1):72-79.
Score: 0.167
-
Mehta TS. Leveraging Differences in AI and Human "Vision" to Improve Breast Cancer Detection. Radiology. 2023 10; 309(1):e232520.
Score: 0.164
-
Ghaderi KF, Phillips J, Perry H, Lotfi P, Mehta TS. Contrast-enhanced Mammography: Current Applications and Future Directions. Radiographics. 2019 Nov-Dec; 39(7):1907-1920.
Score: 0.125
-
Dialani V, Tseng I, Slanetz PJ, Fein-Zachary V, Phillips J, Karimova E, Brook A, Mehta TS. Potential role of abbreviated MRI for breast cancer screening in an academic medical center. Breast J. 2019 07; 25(4):604-611.
Score: 0.122
-
Feliciano-Rivera YZ, Net J, Sanchez P, Wahab RA, Mehta T, Yepes MM. Culturally Competent Care in the Breast Imaging Clinic: Hispanic/Latino Patients. J Breast Imaging. 2023 03 20; 5(2):188-194.
Score: 0.039
-
Mehta TS, Lourenco AP, Niell BL, Bennett DL, Brown A, Chetlen A, Freer P, Ivansco LK, Jochelson MS, Klein KA, Malak SF, McCrary M, Mullins D, Neal CH, Newell MS, Ulaner GA, Moy L. ACR Appropriateness Criteria? Imaging After Breast Surgery. J Am Coll Radiol. 2022 11; 19(11S):S341-S356.
Score: 0.038
-
Brown A, Lourenco AP, Niell BL, Cronin B, Dibble EH, DiNome ML, Goel MS, Hansen J, Heller SL, Jochelson MS, Karrington B, Klein KA, Mehta TS, Newell MS, Schechter L, Stuckey AR, Swain ME, Tseng J, Tuscano DS, Moy L. ACR Appropriateness Criteria? Transgender Breast Cancer Screening. J Am Coll Radiol. 2021 11; 18(11S):S502-S515.
Score: 0.036
-
Son D, Phillips J, Mehta TS, Mehta R, Brook A, Dialani VM. Patient preferences regarding use of contrast-enhanced imaging for breast cancer screening. Acad Radiol. 2022 01; 29 Suppl 1:S229-S238.
Score: 0.035
-
Schonberg MA, Davis RB, Karamourtopoulos MC, Pinheiro A, Sternberg SB, Jacobson AR, Aliberti GM, Mehta TS, Cluett JL, Cohen ML, Atlas T, Tung NM. A Pre-Test-Post-Test Trial of a Breast Cancer Risk Report for Women in Their 40s. Am J Prev Med. 2020 09; 59(3):343-354.
Score: 0.033
-
Kim G, Phillips J, Cole E, Brook A, Mehta T, Slanetz P, Fishman MDC, Karimova E, Mehta R, Lotfi P, Resteghini N, Raj S, Dialani V. Comparison of Contrast-Enhanced Mammography With Conventional Digital Mammography in Breast Cancer Screening: A Pilot Study. J Am Coll Radiol. 2019 Oct; 16(10):1456-1463.
Score: 0.030
-
Phillips J, Miller MM, Mehta TS, Fein-Zachary V, Nathanson A, Hori W, Monahan-Earley R, Slanetz PJ. Contrast-enhanced spectral mammography (CESM) versus MRI in the high-risk screening setting: patient preferences and attitudes. Clin Imaging. 2017 Mar - Apr; 42:193-197.
Score: 0.026